covid 19 News and Research

RSS

UVA receives $4.4 million federal grant to expand Interactive Home Monitoring program

A three-year, $4.4 million Federal Communications Commission grant will enable UVA Health to expand its Interactive Home Monitoring care for patients with serious and chronic conditions, including COVID-19 and diabetes.

27 Jan 2021

New model could help clinicians to safely allow two patients to share a single ventilator

As Covid-19 continues to put pressure on healthcare providers around the world, engineers at the University of Bath have published a mathematical model that could help clinicians to safely allow two people to share a single ventilator.

27 Jan 2021

COVID-19 mortality rates higher in pregnant women than in similarly aged individuals

Contracting COVID-19 while pregnant can have deadly consequences for the mother, a new study published today in American Journal of Obstetrics and Gynecology shows.

27 Jan 2021

Biliverdin shields SARS-CoV-2 from host antibody response, study finds

A team of international scientists has recently revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interacts with two heme metabolites, bilirubin and biliverdin, to escape the antibody-mediated host immune responses.

27 Jan 2021

Anakinra shows therapeutic potential in critically ill COVID-19 patients

A team of international scientists recently conducted an open-level clinical trial to investigate the effects of personalized immunotherapy on critically ill COVID-19 patients.

27 Jan 2021

CDC researchers back U.S. school re-openings but with strict COVID-19 regulations

As the U.S. continues to grapple with surging cases and the complex logistics of mass vaccination, is the country in a position to fully re-open its schools for in-person learning? Researchers at the Centers for Disease Control and Prevention (CDC) think so – notwithstanding a few very important caveats.

27 Jan 2021

Study describes a safe potential therapeutic tool for liver regeneration

A new study led by researchers at the Center for Regenerative Medicine at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) now describes a safe new potential therapeutic tool for the recovery of liver function in chronic and acute liver diseases.

27 Jan 2021

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

Heart disease remains the leading cause of death worldwide, according to the American Heart Association's Heart Disease and Stroke Statistics -- 2021 Update, published today in the Association's flagship journal Circulation, and experts warn that the broad influence of the COVID-19 pandemic will likely continue to extend that ranking for years to come.

27 Jan 2021

Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

Researchers have described the potential of the drug spironolactone, a potassium-sparing diuretic, and anti-androgen, in preventing or alleviating the severity of COVID-19 pneumonia, and in preventing pulmonary fibrosis.

27 Jan 2021

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.

27 Jan 2021

If I have cancer, dementia or MS, should i get the covid vaccine?

As public demand grows for limited supplies of covid-19 vaccines, questions remain about the vaccines' appropriateness for older adults with various illnesses.

27 Jan 2021

What do we know about the SARS-CoV-2 vaccines so far?

A new study surveys what we know so far about SARS-CoV-2 vaccine candidates from advanced clinical trials.

27 Jan 2021

Purdue University-affiliated startup receives NSF grant to study severe COVID-19 cases

A Purdue University-affiliated startup is receiving national support to pursue a strategy to treat severe COVID-19 cases and possible future outbreaks involving other viruses.

27 Jan 2021

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics of Hørsholm, Denmark, today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the "British variant"), at the COVID-19 Testing Service Center (CTSC) of Northern Arizona University's Pathogen and Microbiome Institute (PMI), a leading U.S. infectious disease testing center.

27 Jan 2021

Medicaid expansion helps detect more numbers of undiagnosed HIV infections

The Medicaid expansion facilitated by the Affordable Care Act led to increases in the identification of undiagnosed HIV infections and in the use of HIV prevention services such as preexposure prophylaxis drugs, says new research co-written by a team of University of Illinois Urbana-Champaign experts who study the intersection of health care and public policy.

27 Jan 2021

Eviction moratoria and relief from utility disconnections reduce COVID-19 cases

Policies that helped financially struggling Americans stay in their homes and keep access to water and electricity during the COVID-19 pandemic also helped reduce the spread of the virus, according to a new analysis by Duke University researchers.

27 Jan 2021

New ACR Steering Committee established to guide diagnostic testing during COVID-19 pandemic

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today announced the formation of the AMP COVID Response (ACR) Steering Committee to help coordinate and communicate the organization's continued efforts to guide diagnostic testing during the ongoing COVID-19 pandemic and preparations for future emerging outbreaks.

27 Jan 2021

covid 19 News and Research

UVA receives $4.4 million federal grant to expand Interactive Home Monitoring program

New model could help clinicians to safely allow two patients to share a single ventilator

COVID-19 mortality rates higher in pregnant women than in similarly aged individuals

Biliverdin shields SARS-CoV-2 from host antibody response, study finds

Anakinra shows therapeutic potential in critically ill COVID-19 patients

CDC researchers back U.S. school re-openings but with strict COVID-19 regulations

Study describes a safe potential therapeutic tool for liver regeneration

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

If I have cancer, dementia or MS, should i get the covid vaccine?

What do we know about the SARS-CoV-2 vaccines so far?

Purdue University-affiliated startup receives NSF grant to study severe COVID-19 cases

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Medicaid expansion helps detect more numbers of undiagnosed HIV infections

Eviction moratoria and relief from utility disconnections reduce COVID-19 cases

New ACR Steering Committee established to guide diagnostic testing during COVID-19 pandemic

Study sheds new light on digital contact tracing to control the spread of COVID-19

Higher minimum wage will reduce infant deaths, shows study

Study: Use of online messaging and social media apps spiked during COVID-19 pandemic

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News